Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Genetic Variation of G6PD and CYP2D6: Clinical Implications on the Use of Primaquine for Elimination of Plasmodium vivax

Frontiers in Pharmacology(2021)10.3389/fphar.2021.784909Source: DataRank Database

Genetic Variation of G6PD and CYP2D6: Clinical Implications on the Use of Primaquine for Elimination of Plasmodium vivax is a research paper published in Frontiers in Pharmacology (2021). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 2.67)OA: goldTopics (25)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Peter A. Zimmerman ORCID,James McCarthy ORCID,Alexandra Stewart ORCID

Live enrichment

PubMed:34899347 OpenAlex:https://openalex.org/W3217497996

National Institutes of Health

Grant: 1R01AI148469

FWCI

2.67

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fphar.2021.784909/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fphar.2021.784909/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fphar.2021.784909/full

journalhttps://doi.org/10.3389/fphar.2021.784909

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34899347

Fields of Study

Neonatal Health and BiochemistryPharmacogenetics and Drug MetabolismPharmacological Effects and Toxicity Studies

Keywords

PrimaquinePlasmodium vivaxPharmacogeneticsPharmacologyMalariaMedicineMass drug administrationPopulationGlucosephosphate Dehydrogenase DeficiencyBiologyGenotypePlasmodium falciparumImmunologyChloroquineGeneticsEnvironmental healthGeneGlucose-6-phosphate dehydrogenaseCYP2D6G6PD (glucose-6-phosphate dehydrogenase)eliminationmass drug administration (MDA)

Sustainable Development Goals

SDG 0: Good health and well-being